• Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Home
  • Events
  • Careers at CAPTIS
  • Log In / Sign In ▼
    • Log In with LinkedIn
    • Register w/out LinkedIn
    • Login w/out LinkedIn
    • Reset Lost Password
  • 🔒 MEMBER AREA ▼
    • View your profile
    • Edit your profile
    • Log out
       ☎ US Offices 1 (800) 445-1839 Toll Free | Europe/Int'l +41 22 518 2100
CAPTIS Executive Search
  • Home
  • You are a Business
    • Executive Search
    • Our Commitments
    • Other Services
    • Our Locations
    • About Us
    • Key Values
  • You are a Healthcare Executive
    • Dealing with CAPTIS
    • Candidate Contact Form
    • Login with LinkedIn
    • Create an Account
    • Log in (Existing Account)
    • WW Trade Shows
      • Medical & Pharmaceutical
      • Orthopedics
      • Spine
      • Cardiovascular
      • Diagnostics
      • Wound Care
      • Plastic & Aesthetic Surgery
      • Surgery
      • Trauma
      • Pediatric Care
    • Industry News
      • News
      • Wall Street Beat
      • Business/Financial News
      • Clinical Trials
      • Musculoskeletal News Roundup
      • Cardiovascular
      • M&A Activity
      • Food & Drug Administration (FDA)
      • Wound Care
      • Practice Management
  • CAPTIS Magazine
    • Healthcare News
    • @CaptisCorp Twitter Timeline
    • Healthcare Events
    • CAPTIS LinkedIn Timeline
    • Articles ➜
      • Recruiting
      • Personal Development
      • News
  • Make an Inquiry
  • Contact Us
    • General Contact Form
    • Healthcare Executive Contact
    • Apply for a position at CAPTIS
    • Call 1 800 445 1839
      (Cell/Mobile US & Canada Toll Free, or Skype)
    • Call +41 22 518 2100
      (Cell/Mobile Swiss Landline Switchboard, or Skype)
  • Search
  • Menu

Captare. Aestimare. Eligere. Succedere.

CAPTIS – Your Global Healthcare & MedTech Executive Search Provider

You are a Business

You are an Executive

Want to work at CAPTIS

Learn about our services

 

 

Executive Search
Submit an inquiry

GET HEADHUNTED!

Create and/or update

your confidential profile

 

Healthcare Executive General Information
Create an account & Add your profile

Go to our Careers page

 

 

 

 

 

CAPTIS Careers

Recent Healthcare News:

02/21/2019/by CAPTIS

Propeller Health study suggests 84% of asthma inhaler use performed incorrectly

ResMed (NYSE:RMD) subsidiary Propeller Health today…
02/21/2019/by CAPTIS

LivaNova wins Japanese reimbursement for Perceval aortic valve

02/21/2019/by CAPTIS

Acelity’s KCI launches Abthera NPWT system in Japan

02/21/2019/by CAPTIS

ARS Pharmaceuticals wins fast track status for epinephrine nasal spray

02/21/2019/by CAPTIS

Mauna Kea, Cook Medical terminate Cellvizio dev, distro deal

02/21/2019/by CAPTIS

Axonics Modulation touts results of sacral neuromodulation study

02/21/2019/by CAPTIS

CorMatrix launches FDA IDE Cor Tricuspid ECM cardiac valve trial

02/21/2019/by CAPTIS

Philips wins FDA nod for DigitalDiagnost C90 digital radiography system

02/21/2019/by CAPTIS

Teleflex shares droop on Q4, 2018 earnings release, restructuring announcement

02/21/2019/by CAPTIS

Report: Medtronic to close Portsmouth, N.H. transformative solutions facility

02/21/2019/by CAPTIS

Late mortality rates ‘inadvertently reversed’ in 5-year study of paclitaxel-eluting stent

The journal Circulation said this week that the all-cause…
02/21/2019/by CAPTIS

NuVasive shares rise on Q4, 2018 EPS beat

02/21/2019/by CAPTIS

LivaNova touts CMS trial clearance for vagus nerve depression treatment system

02/21/2019/by CAPTIS

Sosei Heptares doses first patient in trial targeting endocrine disorders

02/21/2019/by CAPTIS

FTC, Teva reach global settlement to resolve reverse-payment charges

02/21/2019/by CAPTIS

Indivior introduces generic version of Suboxone opioid drug in US

02/20/2019/by CAPTIS

Peloton Therapeutics secures $150m in Series E financing

02/20/2019/by CAPTIS

Phillips-Medisize is offering connected health data services: Here’s how

02/20/2019/by CAPTIS

Abbott, Novo Nordisk ink deal for digital diabetes tools

02/20/2019/by CAPTIS

Ocular Therapeutix doses first wet-AMD patient in implant trial

Go to the Healthcare News

Recent news from your industry: Finance, M&A, Products, Companies and more…

Upcoming Events:

We Suggest:

Neovasc inks $3m settlement deal with MID, raises $1m

0 Comments
/
02/20/2019
Neovasc (NSDQ:NVCN) said today that it inked a $3 million…
Read more
https://www.captis.com/wp-content/uploads/2019/02/neovasc-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 11:16:182019-02-20 12:31:06Neovasc inks $3m settlement deal with MID, raises $1m

Hygieia wins FDA clearance for insulin management app

0 Comments
/
02/20/2019
Hygieia said today that it won 510(k) clearance from the…
Read more
https://www.captis.com/wp-content/uploads/2019/02/hygieia-logo-small-150x86.png 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 11:04:102019-02-20 12:31:04Hygieia wins FDA clearance for insulin management app

Owens & Minor dips on Q4, 2018 EPS miss

0 Comments
/
02/20/2019
Shares in Owens & Minor (NYSE:OMI) fell today after…
Read more
https://www.captis.com/wp-content/uploads/2019/02/Owens-Minor-150x97.png 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 10:39:082019-02-20 12:01:04Owens & Minor dips on Q4, 2018 EPS miss

Henry Schein shares drop on mixed bag Q4 earnings

0 Comments
/
02/20/2019
Shares in Henry Schein (NSDQ:HSIC) fell today after the…
Read more
https://www.captis.com/wp-content/uploads/2019/02/henry-schein-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 10:10:162019-02-20 11:31:05Henry Schein shares drop on mixed bag Q4 earnings

Medtronic launches DBS for medically-refractory epilepsy in the U.S.

0 Comments
/
02/20/2019
Medtronic (NYSE:MDT) said today that it launched its Deep…
Read more
https://www.captis.com/wp-content/uploads/2019/02/medtronic-large-updated-150x97-6.png 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 08:19:572019-02-20 09:31:03Medtronic launches DBS for medically-refractory epilepsy in the U.S.

ResMed, Fisher & Paykel agree to settle all outstanding patent suits

0 Comments
/
02/20/2019
ResMed (NYSE:RMD) and Fisher & Paykel Healthcare (NZE:FPH)…
Read more
https://www.captis.com/wp-content/uploads/2019/02/resmed-fisher-paykel-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 07:35:302019-02-20 09:01:45ResMed, Fisher & Paykel agree to settle all outstanding patent suits

Edwards Lifesciences wins CE Mark for Pascal mitral repair device

0 Comments
/
02/20/2019
Edwards Lifesciences (NYSE:EW) said late yesterday that…
Read more
https://www.captis.com/wp-content/uploads/2019/02/edwards-lifesciences-large-150x97-1.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 07:12:162019-02-20 08:31:04Edwards Lifesciences wins CE Mark for Pascal mitral repair device

AdvaMed president & CEO Scott Whitaker to participate in keynote interview at DeviceTalks Boston 2019

0 Comments
/
02/20/2019
WTWH Media and MassDevice.com announced today that Scott Whitaker,…
Read more
https://www.captis.com/wp-content/uploads/2019/02/devicetalks-boston-scott-whitaker-updated-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 06:46:252019-02-20 08:01:07AdvaMed president & CEO Scott Whitaker to participate in keynote interview at DeviceTalks Boston 2019

Apollo Endosurgery touts results of stomach-stapling study

0 Comments
/
02/20/2019
  Apollo Endosurgery’s OverStitch device Apollo Endosurgery (NSDQ:APEN)…
Read more
https://www.captis.com/wp-content/uploads/2019/02/ApolloEndoSurgeryOverStitch-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 06:45:242019-02-20 08:01:04Apollo Endosurgery touts results of stomach-stapling study

Medtronic looks to retire up to $5b in debt

0 Comments
/
02/20/2019
Medtronic (NYSE:MDT) today announced a cash tender offer…
Read more
https://www.captis.com/wp-content/uploads/2019/02/medtronic-large-updated-150x97-5.png 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 05:48:072019-02-20 07:01:57Medtronic looks to retire up to $5b in debt

FTC gives the go ahead to Fresenius, NxStage merger

0 Comments
/
02/20/2019
The U.S. Federal Trade Commission said yesterday that it cleared…
Read more
https://www.captis.com/wp-content/uploads/2019/02/nxstage-fresenius-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 05:27:092019-02-20 06:31:51FTC gives the go ahead to Fresenius, NxStage merger

When human factor specialists become the patient

0 Comments
/
02/20/2019
By Allison Strochlic, Emergo Group I just had a baby –…
Read more
https://www.captis.com/wp-content/uploads/2019/02/emergo-1x1-1.jpg 150 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 03:00:222019-02-20 04:01:23When human factor specialists become the patient

Innovation Pharmaceuticals receives new patent for compounds for use in treatment of oral mucositis

0 Comments
/
02/20/2019
The patent (U.S. Patent Number 10206894) covers methods for treating…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-20 00:31:132019-02-20 01:31:14Innovation Pharmaceuticals receives new patent for compounds for use in treatment of oral mucositis

Roche secures FDA priority review for entrectinib and polatuzumab vedotin

0 Comments
/
02/19/2019
Entrectinib has been granted priority review for the treatment…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-19 23:31:592019-02-20 00:31:59Roche secures FDA priority review for entrectinib and polatuzumab vedotin

Pfizer secures approval from European Commission for Avastin biosimilar

0 Comments
/
02/19/2019
“Pfizer is dedicated to increasing access to biosimilars…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-19 23:31:562019-02-20 00:31:57Pfizer secures approval from European Commission for Avastin biosimilar

Merck gets FDA nod for Keytruda as adjuvant treatment for melanoma

0 Comments
/
02/19/2019
The recommended dose of Keytruda for the adjuvant treatment of…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-19 23:31:502019-02-20 00:31:53Merck gets FDA nod for Keytruda as adjuvant treatment for melanoma

Here’s how a new Abbott device is making a difference among neonatal infants

0 Comments
/
02/19/2019
[Image courtesy of Abbott]A recent CBS News report provided a…
Read more
https://www.captis.com/wp-content/uploads/2019/02/Abbott-Piccolo-premie-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-19 12:29:302019-02-19 13:32:10Here’s how a new Abbott device is making a difference among neonatal infants

Conformis: Yale study shows customized knee implants save money

0 Comments
/
02/19/2019
Conformis (NSDQ:CFMS) is touting results of a study that…
Read more
https://www.captis.com/wp-content/uploads/2019/02/Conformis-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-19 11:32:432019-02-19 13:01:20Conformis: Yale study shows customized knee implants save money

Intuitive Surgical wins FDA clearance for robotic-assisted lung biopsy system

0 Comments
/
02/19/2019
Intuitive Surgical’s Ion system includes an articulating…
Read more
https://www.captis.com/wp-content/uploads/2019/02/Intuitive-Surgical-Ion-system-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-19 10:28:322019-02-19 11:31:59Intuitive Surgical wins FDA clearance for robotic-assisted lung biopsy system

Medtronic risk prediction tool could help prevent opioid deaths: Here’s how

0 Comments
/
02/19/2019
Medtronic officials continue to hone their arguments for how…
Read more
https://www.captis.com/wp-content/uploads/2019/02/medtronic-large-updated-300x195-1.png 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-02-19 08:54:102019-02-19 10:01:42Medtronic risk prediction tool could help prevent opioid deaths: Here’s how
PreviousNext

  • Thorough Network

  • Deep Knowledge

  • Comprehensive Process

  • Ethical Approach

  • Confidentiality

  • Assessment Capacity

99%

Percentage of successful project completion

85%

Of placed executives remain with the client company 3 or more years

  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

News from Twitter

Twitter
Dr. Alfredo Figueiredo
Dr. Alfredo Figueiredo
@Lusitanian_

#LowBackPain - a good summary by the European Spine Society @EUROSPINESoc eurospinepatientline… #Orthopaedics #SpineSurgery pic.twitter.com/yo6E…

reply retweet favorite
5:05 am · 02/21/2019 ·
Retweeted by CAPTIS
Twitter
CAPTIS
CAPTIS
@CaptisCorp

Happy President's Day from CAPTIS!

reply retweet favorite
5:06 pm · 02/18/2019
Twitter
Medtronic Spine
Medtronic Spine
@Medtronic_Spine

We are saddened to share the news of the passing of Dr. Yves Cotrel. A pioneer in modern spine surgery, Dr. Cotrel's company Sofamor, was the foundation for what would become Medtronic Spine. Dr. Cotrel's contributions will live on for years to come. Condolences to his family. pic.twitter.com/JJ1Z…

reply retweet favorite
5:27 pm · 02/01/2019 ·
Retweeted by CAPTIS
Twitter
Arab Health
Arab Health
@Arab_Health

The 44th edition of Arab Health is officially now open. #ArabHealth2019 runs until the 31st of January 2019 at the Dubai World Trade Centre and the Conrad Dubai from 10 am to 6 pm. Find out more on our website or download the Arab Health 2019 show app: bit.ly/2n3Z5Q pic.twitter.com/oasI…

reply retweet favorite
5:35 pm · 01/29/2019 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

Cancer is not a ‘one size fits all,’ nor is the way we treat it. We are working to better understand the different ways a cancer can mutate so we can discover new approaches to treat some of the most difficult-to-treat types of the disease. #ReimagineMedicine #ESMO18 pic.twitter.com/41QL…

reply retweet favorite
6:56 pm · 10/24/2018 ·
Retweeted by CAPTIS
Twitter
Epic CV
Epic CV
@Epic_CV

Read carefully employer's directions on how to apply. #resume #resumetips

reply retweet favorite
7:47 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
World Spine Care
World Spine Care
@WorldSpineCare

Here are 5 Tips to Avoid Back Pain from #WorldSpineDay. #Exercise #Posture #Stress #HealthyEating #Strength pic.twitter.com/AT1D…

reply retweet favorite
7:46 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Neurochecklists
Neurochecklists
@neurochecklists

Large-vessel giant cell arteritis: diagnosis, monitoring and management | Rheumatology | Oxford Academic academic.oup.com/rhe…

reply retweet favorite
7:40 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Stryker Endoscopy
Stryker Endoscopy
@StrykerEndo

Scientists have made an unexpected discovery while investigating the triggering factors of #ColonCancer: Cell stress in combination with an altered microbiota in the colon drives tumor growth. Learn more: ow.ly/JxtK30meLTY pic.twitter.com/U51Q…

reply retweet favorite
7:39 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Implantech
Implantech
@Implantech

If you are in Dallas attending the AAFPRS 12th International Symposium of Facial Plastic Surgery don’t miss out on this Breakfast Symposium tomorrow morning with Dr. William Binder that is sponsored by Implantech! #implantech #superiorpatientaesthetics #implantechrewards #aafprs pic.twitter.com/HCzK…

reply retweet favorite
7:38 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
American College of Cardiology
American College of Cardiology
@ACCinTouch

Less than one month left to submit your science for #ACC19! Abstract & case submissions are due Oct. 16. Learn more: ow.ly/4nyf30lYZxh pic.twitter.com/Mnwv…

reply retweet favorite
4:46 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

With #CARTcell therapy, an inactive virus programs T cells with new genetic information to help recognize specific antigens found on normal cells and certain blood cancer cells. As the CAR-T cells multiply, new copies also gain this ability. #CARTCellStory pic.twitter.com/Xuoh…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Make plans to visit the Integra LifeSciences Booth# 919 during Plastic Surgery The Meeting September 28th - October 1st. #Integra_LifeSciences #DurableIsBeautiful #PSTM18 #ASPS #PlasticSurgery pic.twitter.com/8QGv…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Fundamental Surgery
Fundamental Surgery
@FundamentalSurg

We are live at #NASS2018 stand 2649. Get hands-on with the world's leading surgical #simulator in #VR with #haptics and experience the future of surgical training. #wearefundamental fundamentalsurgery.c… pic.twitter.com/NgzA…

reply retweet favorite
4:41 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
TRX Orthopedics
TRX Orthopedics
@TRXOrtho

Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1

reply retweet favorite
8:34 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Corin Group
Corin Group
@corintechnology

All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Omar Ishrak
Omar Ishrak
@MedtronicCEO

Thank you to our @Medtronic employees around the globe! Q3 saw strong, balanced results, with diversified performance in all groups and regions. #MDTEarnings

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Cardiovascular News
Cardiovascular News
@Cardiovasc_bio

#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO

reply retweet favorite
8:32 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Welcome Sravan Emany, our new vice president, treasurer and head of investor relations. investor.integralife… pic.twitter.com/wzt5…

reply retweet favorite
8:31 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
José Luis Maçãs
José Luis Maçãs
@zeluismacas

Read in this edition all about Novartis Oncology’s ground-breaking CAR-T therapy; how SwissMedic is leading the world in terms of regulatory innovation; the story of Actelion’s acquisition by J&J and the subsequent emergence of a new entity – Idorsia. pharmaboardroom.com/…

reply retweet favorite
11:29 am · 02/10/2018 ·
Retweeted by CAPTIS
Follow @CaptisCorp

Follow CAPTIS



CAPTIS
Followon TwitterSubscribeto RSS Feed

We Recommend

Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News

CAPTIS Newsletter

Call CAPTIS

United States Offices
1 (800) 445-1839

(United States & Canada Toll Free)

Europe & International
+41 22 518 2100

© CAPTIS - Executive Search - 2017 - copyright@captis.com
  • Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Events
  • For Healthcare Executives
  • Legal & Privacy Notes, GDPR & Cookies Policy
  • Client Area
X
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
Survey
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK, got itCookies Policy
Scroll to top